UK's Smith & Nephew tumbles after confirming failed J&J deal talks, cutting forecast

By Reuters News

** Shares of British medical products maker Smith & Nephew SN.L down 2.6% at 1088.5p, among top losers on FTSE 100 index .FTSE

** Co confirmed reports that it was approached by Johnson & Johnson JNJ.N earlier this year about a potential merger with its orthopaedics business, but those conversations have now ended

** SN cut annual revenue and profit forecasts due to weak growth in its US orthopaedics unit, and expects it to persist through the final quarter
** Up to Tuesday's close, stock had fallen 9.8%, compared with a 7.25% YTD increase in FTSE 100

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk